18 Mar

EU Teva investigation shows IP’s competition law issues aren’t limited to patent litigation settlements

The European Commission’s enquiry into Teva’s divisional filings is the latest sign of the growing importance of competition law constraints for life sciences IP strategies

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth